Patents for C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes (141,535) |
---|
06/16/2010 | CN101735993A Method for efficiently producing cellulase |
06/16/2010 | CN101735992A Exogenous composite enzyme preparation special for feed industry and preparation method and application thereof |
06/16/2010 | CN101735991A Aggregate-free urate oxidase for preparation of non-immunogenic polymer conjugates |
06/16/2010 | CN101735967A Organic solvent resisting lipase, application thereof and bacteria for producing same |
06/16/2010 | CN101732717A Ttk in diagnosis and as a therapeutic target in cancer |
06/16/2010 | CN101215538B Bacillus licheniformis and application thereof |
06/16/2010 | CN101215537B 地衣芽孢杆菌及其应用 Bacillus and Its Applications |
06/16/2010 | CN101210252B Lepidoptera pest ground substance metalloprotein gene mmp and application thereof |
06/15/2010 | US7737330 a polynucleotide comprising a nucleotide sequence or complement encoding a polypeptide comprising a farnesyltranstransferase beta subunit, used to improve tolerance to drought in mature plants |
06/15/2010 | US7737325 non-human knock-out mammal lacking alpha-1,6-fucosylation, comprising an exogenous gene encoding an antibodies comprising an Fc region bound to a complex N-glycoside-linked sugar chains comprising a reducing end which contains an N-acetylglucosamine |
06/15/2010 | US7737283 Urea substituted with a 5 member nitrogen-containing ring; biological conjugated drug used to modulate of the activation state of p38 kinase protein; antiinflammatory agents; rheumatoid arthritis, asthma, sepsis, toxic shock syndrome, adult respiratory distress syndrome, stroke, reperfusion injury |
06/15/2010 | US7737240 for cells, proteins, DNA or other molecules encapsulation; carragenan, chitosan, hyaluronic acid, cellulose or alginate; with thiophene, aniline or pyrrole polymerizable moiety grafted on |
06/15/2010 | US7736884 biosynthesis of arachidonic acid, eicosapentaenoic acid and/or docosahexaenoic acid, from non-fatty acid substrates through heterologous gene expression of an oxygen requiring pathway in microorganisms |
06/15/2010 | US7736882 biosynthesis of isopentenyl pyrophosphate, terpenes and steroids, using cultures of transformed microorganisms comprising nucleotide sequences that code mevalonate pathway enzymes |
06/15/2010 | US7736881 Antibacterial and herbicidal compounds and system for screening the same |
06/15/2010 | US7736878 Recombinant forms of DNA sequences for a cyclobutane pyrimidine dimer (CPD) glycosylase protein, that are capable of expression at high level, used in topical formulations for treatment of photosensitive or autoimmune disease that are exacerbated by DNA damage from UV light exposure, such as lupus |
06/15/2010 | US7736876 Peptide-forming enzyme gene |
06/15/2010 | US7736875 Dipeptidyl peptidase I crystal structure and its uses |
06/15/2010 | US7736872 cells comprising a translation system comprising an synthetase enzymes encoded by a nucleotide sequence and the complementary polynucleotide sequence; protein biosynthesis |
06/15/2010 | US7736871 Nucleotide sequences coding dipeptide forming enzyme |
06/15/2010 | US7736680 Using mutations to improve Aspergillus phytases |
06/15/2010 | US7736643 A mutant hydrolase protein of Candida comprising an amino acid sequence, where the #219 leucine is replaced by a hydrophilic amino acid selected from glutamine, histidine, arginine, lysine, serine, threonine, aspartic acid and glutamic acid, used in the food and detergent industry |
06/15/2010 | CA2322729C Modification of fatty acid metabolism in plants |
06/15/2010 | CA2319658C Continuous fermentation process |
06/15/2010 | CA2285939C Methods and compositions for synthesis of long chain polyunsaturated fatty acids in plants |
06/15/2010 | CA2284119C Phosphatidyl-3,4,5-triphosphate-dependent protein kinase |
06/15/2010 | CA2269109C Protease for activating clotting factor vii |
06/15/2010 | CA2250000C Methods of modulating melanin synthesis |
06/10/2010 | WO2010065830A1 Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same |
06/10/2010 | WO2010065448A1 Polypeptides having feruloyl esterase activity and polynucleotides encoding same |
06/10/2010 | WO2010064897A1 Farmesene synthase |
06/10/2010 | WO2010064598A1 Mutant gluconate dehydrogenase |
06/10/2010 | WO2010064243A1 GLUTAMYL tRNA SYNTHETASE (GtS) FRAGMENTS |
06/10/2010 | WO2010064142A1 Screening method for the identification of inhibitors of viral entry |
06/10/2010 | WO2010064132A1 Mutants of staphylokinase carrying amino and carboxy-terminal extensions for polyethylene glycol conjugation |
06/10/2010 | WO2010063783A2 Modulating XRN2 |
06/10/2010 | WO2010063718A1 Screening assay for metabolic disease therapeuticals |
06/10/2010 | WO2010063172A1 An elp fusion protein and uses thereof |
06/10/2010 | WO2010031772A3 Alternative butanol production process in a microbial cell |
06/10/2010 | WO2010029378A3 Anti-protozoa compounds |
06/10/2010 | WO2009133462A3 Proteins |
06/10/2010 | WO2009127969A3 Process |
06/10/2010 | WO2009021867A9 Agents containing proteases |
06/10/2010 | US20100146665 Increased Stress Tolerance and Enhanced Yield in Plants |
06/10/2010 | US20100146651 Meganuclease variants cleaving a dna target sequence from the hprt gene and uses thereof |
06/10/2010 | US20100146642 Methods and compositions relating to PBK1 |
06/10/2010 | US20100145071 Small molecule inhibitors of rotamase enzyme activity |
06/10/2010 | US20100144893 Isoprenoid synthases |
06/10/2010 | US20100144847 Fusion polypeptide suitable as a cytotoxin |
06/10/2010 | US20100144841 Control of nk cell function and survival by modulation of ship activity |
06/10/2010 | US20100144837 Diagnosis and treatment of malignant neoplasms |
06/10/2010 | US20100144739 Heterocyclic inhibitors of c-met and uses thereof |
06/10/2010 | US20100144721 Inhibitors of c-met and uses thereof |
06/10/2010 | US20100144707 Pharmacokinetically improved compounds |
06/10/2010 | US20100144575 Alpha-Amylase Mutants |
06/10/2010 | US20100144013 Over expression of foldases and chaperones improves protein production |
06/10/2010 | US20100144012 A single chain homing endonuclease, comprising a first variant of I-CreI having the amino acid sequence of accession number pdb 1g9y; for genome engineering and gene therapy |
06/10/2010 | US20100144011 Crystal growth under microgravity condition |
06/10/2010 | US20100144010 Enzymatic Asymmetric Decarboxylation of Disubstituted Malonic Acids |
06/10/2010 | US20100144009 Extracting And Purifying Lipoxygenase |
06/10/2010 | US20100144008 Treatment of fabry disease |
06/10/2010 | US20100143997 Engineered microorganisms capable of producing target compounds under anaerobic conditions |
06/10/2010 | US20100143986 R-hnl random variants and their use for preparing optically pure, sterically hindered cyanohydrins |
06/10/2010 | US20100143979 Polypeptides having dna polymerase activity |
06/10/2010 | US20100143970 Transglutaminase having disulfide bond introduced therein |
06/10/2010 | US20100143969 Expression of soluble, active eukaryotic glycosyltransferases in prokaryotic organisms |
06/10/2010 | US20100143968 Penicillin-g acylases |
06/10/2010 | US20100143967 Compositions and methods for enhancing the degradation or conversion of cellulose-containing material |
06/10/2010 | US20100143942 Method of detection |
06/10/2010 | US20100143940 (3r)-hydroxyacyl-acp dehydratase enzymes used in the biosynthesis of mycolic acids and use of same for screening antibiotics |
06/10/2010 | US20100143500 Methods and Compositions for Inhibiting GSK-3 In Glial Cell Related Disorders |
06/10/2010 | US20100143457 Extended soluble PH20 polypeptides and uses thereof |
06/10/2010 | US20100143436 Self-assembly of protein-based biomaterials with multiple morphologies |
06/10/2010 | US20100143411 Method for identification of t-lymphocyte antigens |
06/10/2010 | US20100143388 comprise a Fc region comprising complex N-glycoside-linked sugar chains bound to the Fc region; useful for various diseases having high antibody-dependent cell-mediated cytotoxic activity |
06/10/2010 | US20100143360 Human vascular endothelial growth factor 2 |
06/10/2010 | US20100143330 Methods of treating disorders associated with fat storage |
06/10/2010 | US20100143323 Modified phosphatases |
06/10/2010 | US20100143316 Novel strain of bacillus amyloliquefaciens and its use |
06/10/2010 | US20100143308 Akt nucleic acids, polypeptides, and uses thereof |
06/10/2010 | US20100143300 Hepatitis c therapies |
06/10/2010 | US20100143291 Inactivated pepsin fragments for modulating immune system activity against human malignant tumor cells |
06/10/2010 | CA2745853A1 Farnesene synthase |
06/10/2010 | CA2745760A1 Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same |
06/10/2010 | CA2745608A1 Polypeptides having feruloyl esterase activity and polynucleotides encoding same |
06/10/2010 | CA2745205A1 Glutamyl trna synthetase (gts) fragments |
06/09/2010 | EP2194139A1 Biochemical synthesis of 6 amino caproic acid |
06/09/2010 | EP2194133A2 Amylases, nucleic acids encoding them and methods for making and using them |
06/09/2010 | EP2194124A1 Protein kinase c peptide modulators of angiogenesis |
06/09/2010 | EP2194123A1 DNA polymerase fusions and uses thereof |
06/09/2010 | EP2194122A1 Pyruvate carboxylase overexpression for enhanced production of oxaloacetate-derived biochemicals in microbial cells |
06/09/2010 | EP2194119A2 Production of fatty acids and derivatives thereof |
06/09/2010 | EP2193804A2 Recombinant adenylate cyclase toxin of bordetella induces T cell responses against tumoral antigens |
06/09/2010 | EP2193198A2 Amidohydrolases for preparing foodstuffs or stimulants |
06/09/2010 | EP2193197A2 Process for purification of human tissue type plasminogen activator |
06/09/2010 | EP2193194A1 Method for producing 2-methyl-1,2-dihydroxypropane |
06/09/2010 | EP1721973B1 Mutant bacterium belonging to the genus bacillus |
06/09/2010 | EP1685248B1 Oxidoreductase from metschnikowia zobellii |
06/09/2010 | EP1653990B1 Use of polypeptides of the cupredoxin family in cancer therapy |
06/09/2010 | EP1335981B1 18480 human protein kinase molecules and uses therefor |